Scholar Rock Holding Corp. priced its IPO of 5,360,000 common shares at $14 per share.
The Cambridge, Mass.-based biopharmaceutical company expects to raise gross proceeds of about $75 million through the offering, which is expected to close May 29, subject to customary closing conditions.
Underwriters have a 30-day option to buy up to an additional 804,000 common shares at the offering price.
The shares are expected to start trading May 24 on the Nasdaq Global Select Market under the symbol SRRK.
Jefferies LLC, Cowen and Co. LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the offering, with Wedbush Securities Inc. as co-manager.
